CIK: 1488919 - Address: C/o Eiger Biopharmaceuticals, Inc., 2155 Park Blvd., Palo Alto, CA 94306
6 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret21424-3-15-1316223
P%wins757550252510058

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

8/19/16 18:52
8/18/16
EIGREiger Biopharmaceuticals, Inc.HealthBioPrdBiological Products, (No DiagShaffer James PCAOChief BuP4915.70131256D-91-114-21-15-19-17-1255-11-22-29
6/14/16 18:45
6/13/16
EIGREiger Biopharmaceuticals, Inc.HealthBioPrdBiological Products, (No DiagShaffer James PCAOChief BuP2822.17011002D-87-35102724-10-9-3-7-8-33-44
5/23/16 18:37
5/19/16
EIGREiger Biopharmaceuticals, Inc.HealthBioPrdBiological Products, (No DiagShaffer James PCAOChief BuP.m2519.8001New1D-85-3820440-222141-21-36
2/4/14 21:05
2/2/14
HALOHalozyme Therapeutics IncDEHealthBioPrdBiological Products, (No DiagShaffer James PCAOVP,ChiefM.dm00.0025164454D4012610927-1-5-16-7-5610-44-312
2/5/13 20:21
2/2/13
HALOHalozyme Therapeutics IncDEHealthBioPrdBiological Products, (No DiagShaffer James PCAOVP,ChiefM00.0011114338D-5-42-232219-21-21-82-4-15-512112
11/14/12 19:06
11/14/12
HALOHalozyme Therapeutics IncDEHealthBioPrdBiological Products, (No DiagShaffer James PCAOVP,ChiefP1045.2242031726D-28-35-29-9-30-9-2051261556162

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact